{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T04:08:54Z","timestamp":1774930134600,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":4147,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"crossref","award":["31-63784.00"],"award-info":[{"award-number":["31-63784.00"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012654","name":"Olga Mayenfisch Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012654","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Theodor and Ida Herzog-Egli Foundation"},{"name":"Kanton of Zurich"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1093\/annonc\/mdn056","type":"journal-article","created":{"date-parts":[[2008,3,19]],"date-time":"2008-03-19T00:18:21Z","timestamp":1205885901000},"page":"1488-1494","source":"Crossref","is-referenced-by-count":21,"title":["Arsenic trioxide down-regulates antiapoptotic genes and induces cell death in mycosis fungoides tumors in a mouse model"],"prefix":"10.1016","volume":"19","author":[{"given":"A.","family":"Tun-Kyi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-Z.","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.A.","family":"Oberholzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.A.","family":"Navarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.","family":"Hassel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Dummer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"D\u00f6bbeling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdn056_bb0010","first-page":"1061","article-title":"Cutaneous T-cell lymphoma: pathogenesis and treatment","volume":"14","author":"Girardi","year":"2000","journal-title":"Oncology"},{"key":"10.1093\/annonc\/mdn056_bb0015","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1053\/sder.2000.8339","article-title":"Pathogenesis of cutaneous lymphomas","volume":"19","author":"Dummer","year":"2000","journal-title":"Semin Cutan Med Surg"},{"key":"10.1093\/annonc\/mdn056_bb0020","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1172\/JCI24826","article-title":"Immunopathogenesis and therapy of cutaneous T cell lymphoma","volume":"115","author":"Kim","year":"2005","journal-title":"J Clin Invest"},{"issue":"Suppl. 1","key":"10.1093\/annonc\/mdn056_bb0025","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.0303-6987.2006.00497.x","article-title":"Standard and experimental therapy in cutaneous T cell lymphomas","volume":"33","author":"Dummer","year":"2006","journal-title":"J Cutan Pathol"},{"key":"10.1093\/annonc\/mdn056_bb0030","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/0190-9622(90)70112-U","article-title":"Topical carmustine (BCNU) for cutaneous T cell lymphoma: a 15-year experience in 143 patients","volume":"22","author":"Zackheim","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1093\/annonc\/mdn056_bb0035","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1182\/blood.V80.4.879.879","article-title":"Bcl-2 initiates a new category of oncogenes: regulators of cell death","volume":"80","author":"Korsmeyer","year":"1992","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdn056_bb0040","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/path.1341","article-title":"Expression of apoptosis regulators in cutaneous T cell lymphoma (CTCL) cells","volume":"200","author":"Zhang","year":"2003","journal-title":"J. Pathol"},{"key":"10.1093\/annonc\/mdn056_bb0045","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1172\/JCI115920","article-title":"Interleukin-7 is a growth factor for S\u00e9zary lymphoma cells","volume":"90","author":"Dalloul","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1093\/annonc\/mdn056_bb0050","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1200\/JCO.1994.12.2.326","article-title":"Costimulation of cutaneous T-cell lymphoma cells by interleukin-7 and interleukin-2: potential autocrine or paracrine effectors in the Sezary syndrome","volume":"12","author":"Foss","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdn056_bb0055","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/1523-1747.ep12338641","article-title":"Interleukin-15 mRNA is expressed by human keratinocytes, Langerhans cells, and blood derived dendritic cells and is downregulated by ultraviolet B radiation","volume":"106","author":"Blauvelt","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1093\/annonc\/mdn056_bb0060","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1182\/blood.V92.1.252.413k08_252_258","article-title":"IL-15 is an autocrine\/paracrine viability factor for cutaneous T cell lymphoma cells","volume":"92","author":"D\u00f6bbeling","year":"1998","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdn056_bb0065","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1182\/blood.V98.9.2778","article-title":"IL-7 and IL-15 regulate the expression of the bcl-2 and c-myb genes in cutaneous T cell lymphoma (CTCL) cells","volume":"98","author":"Qin","year":"2001","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdn056_bb0070","first-page":"225","article-title":"Cutaneous T cell lymphoma cells contain constitutive NFkB complexes","volume":"108","author":"Qin","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1093\/annonc\/mdn056_bb0075","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1046\/j.0022-202x.2001.01436.x","article-title":"Constitutive and interleukin-7- and interleukin-15-stimulated DNA binding of STAT and novel factors in cutaneous T cell lymphoma cells","volume":"117","author":"Qin","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1093\/annonc\/mdn056_bb0080","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1182\/blood-2005-06-2536","article-title":"Down-regulating constitutive activation of the NF-kappaB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis","volume":"107","author":"Sors","year":"2006","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdn056_bb0085","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/157016307781115467","article-title":"Transcription factor profiling shows new ways towards new treatment options of cutaneous T cell lymphomas","volume":"4","author":"D\u00f6bbeling","year":"2007","journal-title":"Curr Drug Discov Technol"},{"key":"10.1093\/annonc\/mdn056_bb0090","doi-asserted-by":"crossref","first-page":"10057","DOI":"10.1073\/pnas.94.19.10057","article-title":"Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kB control","volume":"94","author":"Chu","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/mdn056_bb0095","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1182\/blood.V88.3.1052.1052","article-title":"In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute pro-myelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of bcl-2 expression and modulation of PML-RAR\u03b1\/PML proteins","volume":"88","author":"Chen","year":"1996","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdn056_bb0100","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJM199811053391901","article-title":"Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide","volume":"339","author":"Soignet","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdn056_bb0105","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1182\/blood.V90.2.562","article-title":"Comparative activity of melarsoprol and arsenic trioxide in chronic B-cell leukemia lines","volume":"90","author":"K\u00f6nig","year":"1997","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdn056_bb0110","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0968-0004(97)01107-9","article-title":"Caspases and caspase inhibitors","volume":"22","author":"Villa","year":"1997","journal-title":"Trends Biochem Sci"},{"key":"10.1093\/annonc\/mdn056_bb0115","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1182\/blood.V89.9.3354","article-title":"Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients","volume":"89","author":"Shen","year":"1997","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdn056_bb0120","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1046\/j.1523-1747.2003.12479.x","article-title":"Arsenic trioxide induces apoptosis of cutaneous T cell lymphoma cells: evidence for a partially caspase-independent pathway and potentiation by ascorbic acid (vitamin C)","volume":"121","author":"Michel","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1093\/annonc\/mdn056_bb0125","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1182\/blood.V93.1.260","article-title":"Constitutive and IL-7\/IL-15 stimulated DNA-binding of Myc, Jun, and novel Myc-like proteins in cutaneous T cell lymphoma cells","volume":"93","author":"Qin","year":"1999","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdn056_bb0130","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.0906-6705.2004.00201.x","article-title":"Establishment of a mouse xenograft model for mycosis fungoides","volume":"13","author":"Thaler","year":"2004","journal-title":"Exp Dermatol"},{"key":"10.1093\/annonc\/mdn056_bb0135","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1089\/ars.2007.1731","article-title":"Bcl-2 family members regulate anoxia-induced cell death","volume":"9","author":"Shroff","year":"2007","journal-title":"Antioxid Redox Signal"},{"key":"10.1093\/annonc\/mdn056_bb0140","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0092-8674(93)90509-O","article-title":"Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death","volume":"74","author":"Oltvai","year":"1993","journal-title":"Cell"},{"key":"10.1093\/annonc\/mdn056_bb0145","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0092-8674(95)90411-5","article-title":"Bad a heteromeric partner for Bcl-xL and Bcl-2, displaces Bax and promotes cell death","volume":"80","author":"Yang","year":"1995","journal-title":"Cell"},{"key":"10.1093\/annonc\/mdn056_bb0150","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1182\/blood.V88.3.809.809","article-title":"Constitutive action of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines","volume":"88","author":"Weber-Nordt","year":"1996","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdn056_bb0155","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1128\/MCB.21.16.5299-5305.2001","article-title":"NF-kappaB signals induce the expression of c-FLIP","volume":"21","author":"Micheau","year":"2001","journal-title":"Mol Cell Biol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419402421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419402421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/19\/8\/1488\/624289\/mdn056.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T08:41:09Z","timestamp":1624437669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419402421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0923753419402421"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdn056","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}